Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 3Phase 3 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Colorectal Neoplasms 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Probiotics × Gastrointestinal × Clear all
NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown
75 enrolled
Gastrointestinal

Anus Neoplasms

NCT00936572 2009-07-10

Probiotics In Colorectal Cancer Patients

University of Milano Bicocca

Phase 2 Completed
35 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00319007 2007-08-10

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Radboud University Medical Center

Phase 2 Unknown
30 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡